Institut National de Santé Publique du Québec, Quebec City, QC G1E 7G9, Canada.
J Infect Dis. 2013 Mar 15;207(6):990-8. doi: 10.1093/infdis/jis923. Epub 2012 Dec 21.
The largest measles epidemic in North America in the last decade, occurred in 2011 in Quebec, Canada, where rates of 1- and 2-dose vaccine coverage among children 3 years of age were 95%-97% and 90%, respectively, with 3%-5% unvaccinated.
Case patients identified through passive surveillance and outbreak investigation were contacted to determine clinical course, vaccination status, and possible source of infection.
There were 21 measles importations and 725 cases. A superspreading event triggered by 1 importation resulted in sustained transmission and 678 cases. The overall incidence was 9.1 per 100,000; the highest incidence was in adolescents 12-17 years old (75.6 per 100,000), who comprised 56% of case patients. Among adolescents, 22% had received 2 vaccine doses. Outbreak investigation showed this proportion to have been an underestimate; active case finding identified 130% more cases among 2-dose recipients. Two-dose recipients had milder illness and a significantly lower risk of hospitalization than those who were unvaccinated or single-dose recipients.
A chance superspreading event revealed an overall level of immunity barely above the elimination threshold when unexpected vulnerability in 2-dose recipients was taken into account. Unvaccinated individuals remain the immunization priority, but a better understanding of susceptibility in 2-dose recipients is needed to define effective interventions if elimination is to be achieved.
2011 年,加拿大魁北克省爆发了近十年来北美最大的麻疹疫情,当时 3 岁儿童的 1 剂和 2 剂疫苗覆盖率分别为 95%-97%和 90%,3%-5%的儿童未接种疫苗。
通过被动监测和疫情调查确定病例患者,并联系他们以确定临床病程、疫苗接种状况和可能的感染源。
共发现 21 例麻疹输入病例和 725 例麻疹病例。1 例输入病例引发的超级传播事件导致了持续传播和 678 例麻疹病例。总发病率为每 10 万人 9.1 例;发病率最高的是 12-17 岁的青少年(75.6/10 万人),占病例患者的 56%。在青少年中,有 22%的人接种了 2 剂疫苗。疫情调查表明,这一比例被低估了;主动病例发现使 2 剂疫苗接种者的病例数增加了 130%。2 剂疫苗接种者的病情较轻,住院风险明显低于未接种疫苗或仅接种 1 剂疫苗的患者。
偶然发生的超级传播事件揭示了整体免疫水平仅略高于消除阈值,而 2 剂疫苗接种者的意外脆弱性则被考虑在内。未接种疫苗的个体仍然是免疫接种的重点,但需要更好地了解 2 剂疫苗接种者的易感性,以便在实现消除目标时确定有效的干预措施。